
Opinion|Videos|November 15, 2024
First Line Treatment Decisions for Age-Related Macular Degeneration
Key Takeaways
Sumit Sharma, MD, FASRS asks the panel what they are using for first-line AMD treatment and what considerations factor into decision making, such as insurance coverage or risk of inflammation.
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmic innovation by the decades: The 2000s
2
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
3
Avisi Technologies’ investigational device exemption for VisiPlate approved by FDA
4
FDA approves Rayner’s RayOne EMV Toric intraocular lens
5